Stromboli is appointed an approved supplier to Massachusetts General Hospital / Partners HealthCare

Stromboli has been appointed an approved supplier to Partners HealthCare. Partners HealthCare, based in Boston, Massachusetts, includes primary care and specialty physicians, the two founding academic medical centres, community and specialty hospitals, and community health centres. In addition to its care giving mission, Partners is one of the nation’s premier biomedical research organizations and is a major teaching affiliate of Harvard Medical School. Partners is a non-profit organization supported in part by charitable contributions.

Stromboli has agreed to develop specialist medical imaging software for use in a ground breaking digital tomosynthesis mammography screening trial.

http://www.mghbreastimaging.org/

Digital Tomosynthesis

Tomosynthesis was conceived more than thirty years ago, but it was MGH’s Kopans who suggested reviving the technique for breast evaluation in conjunction with the development of a digital detector for mammography. Tomosynthesis takes advantage of an effect called parallax in which an object that is closer appears to move a greater distance against the background than an object that is further away when viewed from various angles. X-ray images are obtained from 11 different angles while the breast remains motionless in the mammography system. Computers electronically line up the images so that only the structures in a single plane of the breast line up on all of the images. The technique eliminates the overlapping structures that can obscure a cancer, making abnormalities more visible, since every plane through the breast can be reconstructed from the 11 images. Digital tomosynthesis promises to make cancer lesions easier to see among dense fibroglandular breast tissue. Like other 3D techniques, these images of the breast can be combined to create a 3D view that brings structures into relief, and the image can be rotated in space for more careful examination.